HOME >> MEDICINE >> NEWS
Studies demonstrate positive data in treatment of hepatitis C

BOSTON Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C will be presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) this afternoon.

Presented by principal investigator Nezam Afdhal, M.D., Chief of Hepatology at Beth Israel Deaconess Medical Center (BIDMC) and Associate Professor of Medicine at Harvard Medical School, the new findings provide researchers with sufficient evidence to demonstrate promising results for hepatitis C patients who have not responded to existing therapies.

A viral infection, hepatitis C is transmitted through exposure to infected blood. The virus, which affects an estimated 4 million individuals nationwide, is able to survive and flourish inside the body by taking up residence in the liver cells, and subsequently using the cells' inner machinery to make more copies of the virus. These in turn, infect other healthy cells.

The standard treatment for hepatitis C is a combination of interferon alfa and ribavirin, which act as anti-viral agents to eradicate the virus. According to Afdhal, the most recent advance in treatment has been the pegylation of interferon, which enables a once- a- week administration of the protein by injection and improves the ability to clear the virus. Combination therapy with pegylated interferon plus ribavirin for 24 to 48 weeks can result in eradication of the virus in about 50 percent of patients, he adds.

"When the hepatitis C virus doesn't respond as occurs in about half of all patients who are treated those patients who already have cirrhosis are at a far greater risk for developing liver cancer or suffering liver failure," notes Afdhal. In fact, he says, hepatitis C is the leading cause of liver transplants in the U.S. Until now, no treatment has been available for these patients.

In his first presentation, Afdhal will describe results from the COPILOT [Colchicine versus PEG-INTRON Long-Term
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
1-Nov-2004


Page: 1 2 3

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies examine risk factors and potential consequences associated with prehypertension
8. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
9. Studies identify risk factors for colon cancer
10. Studies indicate healthy eating may affect cancer development, improve digestive system
11. Studies compare hysterectomy vs. other medical treatments for abnormal uterine bleeding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... After many months of preparation, the providers ... Phoenix, Arcadia Allergy & Asthma. This new allergy and asthma clinic is conveniently located ... one stop destination for any immunological and respiratory medical care needs. , In the ...
(Date:1/14/2019)... ... January 15, 2019 , ... Early bird pricing for Medical Device ... management is just plain hard, complicated, conflicted, confusing. And it is getting even more ... are not intended as “major”, the new standard adds new definitions, changes the clause ...
(Date:1/14/2019)... ... ... Reviewed & Approved Living Well Providers of 2019. , Acupuncture, Dr. Wai ... - Maplewood , Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - ... Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - ...
(Date:1/13/2019)... (PRWEB) , ... January 12, 2019 , ... ... Professionals Committee (YPC) in conjunction with Temple University hosted a continuing education (CEU) ... and Mentees. The event aimed to create a series of talks to ...
(Date:1/11/2019)... MINNEAPOLIS (PRWEB) , ... January 11, 2019 , ... ... announced the three finalist teams in its “Next Generation Captive Insurance Solutions for ... by Strategic Risk Solutions. , The three finalist teams are: , ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... ... January 10, 2019 , ... Pelican BioThermal , ... rapidly expand under the leadership of Dominic Hyde, vice president of Credo™ on ... temperature controlled shipper rental program allowing organizations to choose the shipper application that ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... as a kind of partnership. The implicit terms of this partnership hold that ... and administer the most effective treatment to restore the patient to improved health. ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... announced today that Philips, the leading international health technology company, has taken a ... Additional investors include StartUp Health and NueCura Partners. , Babyscripts has spent the ...
Breaking Medicine Technology:
Cached News: